UCSF

Tagged: malaria

Erika Wallender, MD

Assistant Professor

I am an assistant professor in the Department of Clinical Pharmacy. I investigate how to optimally use antimalarials to prevent malaria in vulnerable populations like pregnant women and children. To do this I use computational methods in pharmacology and epidemiology. My goal is optimize the use of...

Data for a difference

Low-cost drug treatments can cure TB and malaria. Why, then, do these diseases claim so many lives?

Update from the Dean - March 2017

Nation debates possibility of dramatically new directions for health care coverage, science funding, immigration, education; Revealing malaria/HIV drug interactions in children; Decreasing cancer drug toxicity while increasing dose; Engineering safer opioids; Evidence for comprehensive medication...

Renewed funding for Aweeka study on malaria treatment for children with HIV in Africa

Fran Aweeka, PharmD, will receive renewed funding for her grant from the National Institutes of Health for evaluating the pharmacology of antimalarial drugs in children in Africa. This is a renewal of her R01 on this important work, and will provide five years of funding for Aweeka and her...

Aweeka study details impact of HIV drugs on malaria treatment in children

Sub-Saharan Africa is home to a billion people and to overlapping health burdens, including the world’s highest rates of both malaria and HIV infection.

Liusheng Huang, PhD

Associate Director

As associate director of the Drug Research Unit (DRU), I bring nearly 20 years experience in analytical development and focus on development of novel methods for some of the most critical but understudied drugs in the world, such as drugs for malaria. My research interest is in optimizing these...

Fran Aweeka, PharmD

Professor

I am a clinical scientist and professor. My primary areas of interest include the pharmacology of drugs for HIV, malaria, and tuberculosis. I direct a laboratory, Drug Research Unit, that supports this research and the research of other UCSF investigators and researchers at other national and...

Rada Savic, PhD

Professor

I investigate the causes of variations in clinical outcomes, using computational methods. My goal is to determine the optimal dosage, timing, and duration of therapeutic regimens. Ultimately, I want to develop precise, personalized treatments.

Nancy Sambol, PharmD

BTS PharmD Acad Coordinator

I focus on the use of models to describe drug disposition and effect in patient populations, and the use of these models to make predictions to improve drug therapy.

New NIH funding awarded to the Department of Clinical Pharmacy in 2011

New research support awarded to the UCSF School of Pharmacy by the National Institutes of Health during the 2011 fiscal year included these on-going projects by faculty in the Department of Clinical Pharmacy:

Pages